{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:48:08Z","timestamp":1756993688697},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1990,1]]},"DOI":"10.1007\/bf01857636","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T02:57:13Z","timestamp":1120186633000},"page":"221-228","source":"Crossref","is-referenced-by-count":2,"title":["Renal effects of angiotensin converting enzyme inhibitors: Nondiabetic chronic renal disease"],"prefix":"10.1007","volume":"4","author":[{"given":"John A.","family":"Opsahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01857636_CR1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ki.1983.72","volume":"23","author":"BM Brenner","year":"1983","unstructured":"Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.Kidney Int 1983;23:647\u2013655.","journal-title":"Kidney Int"},{"key":"BF01857636_CR2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJM198207223070403","volume":"307","author":"BM Brenner","year":"1982","unstructured":"Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.N Engl J Med 1982;307:652\u2013659.","journal-title":"N Engl J Med"},{"key":"BF01857636_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ki.1988.18","volume":"33","author":"LG Fine","year":"1988","unstructured":"Fine LG. Preventing the progression of human renal disease: Have rational therapeutic principles emerged.Kidney Int 1988;33:116\u2013128.","journal-title":"Kidney Int"},{"key":"BF01857636_CR4","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198806233182505","volume":"318","author":"S Klahr","year":"1988","unstructured":"Klahr S, Schreiner G, Ichikawa I: The progression of renal disease.N Engl J Med 1988;318:1657\u20131666.","journal-title":"N Engl J Med"},{"key":"BF01857636_CR5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000167599","volume":"8","author":"WF Keane","year":"1988","unstructured":"Keane WF, Kasiske BL: O'Connell MP: Lipids and progressive glomerulosclerosis.Am J Nephrol 1988;8:261\u2013271.","journal-title":"Am J Nephrol"},{"key":"BF01857636_CR6","doi-asserted-by":"crossref","unstructured":"Brenner BM: Nephron adaptation to renal injury or ablation.Am J Physiol 1985;249 (Renal Fluid Electrolyte Physiol 18) 1985;F324\u2013F337.","DOI":"10.1152\/ajprenal.1985.249.3.F324"},{"key":"BF01857636_CR7","doi-asserted-by":"crossref","unstructured":"Meyer TW, Rennke HG. Progressive glomerular injury after limited renal infarction in the rat.Am J Physiol 1988;254 (Renal Fluid Electrolyte Physiol 23):F856\u2013F862.","DOI":"10.1152\/ajprenal.1988.254.6.F856"},{"key":"BF01857636_CR8","doi-asserted-by":"crossref","unstructured":"Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation.Am J Physiol 1981;241 (Renal Fluid Electrolyte Physiol 10):F85\u2013F93.","DOI":"10.1152\/ajprenal.1981.241.1.F85"},{"key":"BF01857636_CR9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","volume":"76","author":"S Anderson","year":"1985","unstructured":"Anderson S, Meyer TW, Rennke HG, et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.J Clin Invest 1985;76:612\u2013619.","journal-title":"J Clin Invest"},{"key":"BF01857636_CR10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ki.1987.62","volume":"31","author":"TW Meyer","year":"1987","unstructured":"Meyer TW, Anderson S, Rennke HG, et al. Reversing glomerular hypertension stabilizes established glomerular injury.Kidney Int 1987;31:752\u2013759.","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"BF01857636_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(85)90078-6","volume":"79","author":"L Raij","year":"1985","unstructured":"Raij L, Chiou X-C, Owens R, et al. Therapeutic implications of hypertension-induced glomerular injury.Am J Med 1985;79 (Suppl 3C):37\u201341.","journal-title":"Am J Med"},{"key":"BF01857636_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00004872-198806000-00010","volume":"6","author":"B Jackson","year":"1988","unstructured":"Jackson B, Johnston CI. The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: Effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.J Hypertens 1988;6:495\u2013501.","journal-title":"J Hypertens"},{"key":"BF01857636_CR13","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","volume":"77","author":"S Anderson","year":"1986","unstructured":"Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.J Clin Invest 1986;77:1993\u20132000.","journal-title":"J Clin Invest"},{"key":"BF01857636_CR14","doi-asserted-by":"crossref","unstructured":"Nath KA, Kren SM, Hostetter TH. Dietary protein restriction in established renal injury in the rat: Selective role of glomerular capillary pressure in progressive glomerular dysfunction.J Clin Invest 78:1199\u20131205.","DOI":"10.1172\/JCI112703"},{"key":"BF01857636_CR15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0041-008X(85)90397-7","volume":"80","author":"RL Hall","year":"1985","unstructured":"Hall RL, Wilke WL, Fettman MJ. Captopril slows the progression of chronic renal disease in partially nephrectomized rats.Toxicol Appl Pharmacol 1985;80:517\u2013526.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF01857636_CR16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/00313028709065133","volume":"19","author":"B Jackson","year":"1987","unstructured":"Jackson B, Whitty M, Debrevi L, et al. Preservation of renal structure and function in the rat remnant kidney model of chronic renal failure by enalapril treatment.Pathology 1987;19:38\u201342.","journal-title":"Pathology"},{"key":"BF01857636_CR17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1172\/JCI113590","volume":"82","author":"A Fogo","year":"1988","unstructured":"Fogo A, Yoshida Y, Glick AD, et al. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.J Clin Invest 1988;82:322\u2013330.","journal-title":"J Clin Invest"},{"key":"BF01857636_CR18","unstructured":"O'Donnell MP, Kasiske BL, Katz SA, et al. Enalapril (E) reduces glomerular injury in obese Zucker (OZ) rats. (abstract). Proceedings of the 21st Annual Meeting of the American Society of Nephrology, 1988, 286A."},{"key":"BF01857636_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1172\/JCI101467","volume":"23","author":"DP Earle Jr","year":"1944","unstructured":"Earle DP Jr, Taggart JV, Shannon JA. Glomerulonephritis. A survey of the functional organization of the kidney in various stages of diffuse glomerulonephritis.J Clin Invest 1944;23:119\u2013137.","journal-title":"J Clin Invest"},{"key":"BF01857636_CR20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-28-3-560","volume":"28","author":"AC Corcoran","year":"1948","unstructured":"Corcoran AC, Taylor RD, Page IH. Functional patterns in renal disease.Ann Intern Med 1948;28:560\u2013582.","journal-title":"Ann Intern Med"},{"key":"BF01857636_CR21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/0002-9343(50)90292-0","volume":"9","author":"SE Bradley","year":"1950","unstructured":"Bradley SE, Bradley GP, Tyson CJ, et al. Seminars in renal physiology: Renal function in renal diseases.Am J Med 1950;9:766\u2013798.","journal-title":"Am J Med"},{"key":"BF01857636_CR22","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1001\/archinte.1986.00360230061010","volume":"146","author":"GP Reams","year":"1986","unstructured":"Reams GP, Bauer JH: Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction.Arch Intern Med 1986;146:2145\u20132148.","journal-title":"Arch Intern Med"},{"key":"BF01857636_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ki.1987.174","volume":"32","author":"JE Heeg","year":"1987","unstructured":"Heeg JE, DeJong PE, Van Der Hem GK, et al. Reduction of proteinuria by angiotensin converting enzyme inhibition.Kidney Int 1987;32:78\u201383.","journal-title":"Kidney Int"},{"key":"BF01857636_CR24","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1001\/archinte.1988.00380110024005","volume":"148","author":"PA Abraham","year":"1988","unstructured":"Abraham PA, Opsahl JA, Halstenson CE. et al. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.Arch Intern Med 1988; 148:2358\u20132362.","journal-title":"Arch Intern Med"},{"key":"BF01857636_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000183318","volume":"38","author":"H Herlitz","year":"1984","unstructured":"Herlitz H, Edeno C, Mulec H, et al. Captopril treatment of hypertension and renal failure in systemic lupus erythematosus.Nephron 1984;38:253\u2013256.","journal-title":"Nephron"},{"issue":"Suppl 20","key":"BF01857636_CR26","first-page":"S112","volume":"31","author":"JGG Ledingham","year":"1987","unstructured":"Ledingham JGG. Effects of angiotensin II and of angiotensin converting enzyme inhibition in chronic renal failure.Kidney Int 1987;31 (Suppl 20):S112\u2013S116.","journal-title":"Kidney Int"},{"key":"BF01857636_CR27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0002-9149(82)90363-0","volume":"49","author":"AEG Raine","year":"1982","unstructured":"Raine AEG, Phil D, Ledingham JCG. Clinical experience with captopril in the treatment of severe drug-resistant hypertension.Am J Cardiol 1982;49:1475\u20131479.","journal-title":"Am J Cardiol"},{"key":"BF01857636_CR28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0002-9343(88)90584-0","volume":"85","author":"E Valvo","year":"1988","unstructured":"Valvo E, Bedogna V, et al. Captopril in patients with type II diabetes and renal insufficiency: Systemic and renal hemodynamic alterations.Am J Med 1988;85:344\u2013348.","journal-title":"Am J Med"},{"issue":"4 & 5","key":"BF01857636_CR29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/10641968609046602","volume":"8","author":"F Bouissou","year":"1986","unstructured":"Bouissou F, Meguira B, Rostin M, et al. Long term therapy by captopril in children with renal hypertension.Clin Exp Theory Practice 1986;A8 (4 & 5):841\u2013845.","journal-title":"Clin Exp Theory Practice"},{"issue":"2 & 3","key":"BF01857636_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/10641968709164222","volume":"9","author":"H Shionoiri","year":"1987","unstructured":"Shionoiri H, Yasuda G, Takagi N, et al. Renal haemodynamics and comparative effects of captopril in patients with benign-or malignant-essential hypertension, or with chronic renal failure.Clin Exp Theory Practice 1987;A9 (2 & 3):543\u2013549.","journal-title":"Clin Exp Theory Practice"},{"issue":"Suppl III","key":"BF01857636_CR31","doi-asserted-by":"crossref","first-page":"III152","DOI":"10.1161\/01.HYP.5.5_Pt_2.III152","volume":"5","author":"S Bj\u00f6rck","year":"1983","unstructured":"Bj\u00f6rck S, Herlitz H, Nyberg G, et al. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.Hypertension 1983;5 (Suppl III):III152\u2013III153.","journal-title":"Hypertension"},{"key":"BF01857636_CR32","first-page":"S204","volume":"34","author":"P Coratelli","year":"1988","unstructured":"Coratelli P, Buongiorno E, Giannattasio M, et al. Antihypertensive efficacy of enalapril maleate on impaired renal function.Kidney Int 1988;34:S204\u2013S206.","journal-title":"Kidney Int"},{"key":"BF01857636_CR33","first-page":"280","volume":"20","author":"WD Cooper","year":"1985","unstructured":"Cooper WD, Doyle G, Donohoe J, et al. Enalapril in the treatment of hypertension associated with impaired renal function.Br J Clin Pharmac 1985;20:280\u2013281.","journal-title":"Br J Clin Pharmac"},{"issue":"Suppl 3","key":"BF01857636_CR34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9343(88)90347-6","volume":"85","author":"JF Donohoe","year":"1988","unstructured":"Donohoe JF, Kelly J, Laher MS et al. Lisinopril in the treatment of hypertensive patients with renal impairment.Am J Med 1988;85 (Suppl 3B):31\u201334.","journal-title":"Am J Med"},{"key":"BF01857636_CR35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000429300","volume":"41","author":"K Delin","year":"1984","unstructured":"Delin K, Aurell M, Herlitz H. Captopril in the treatment of hypertension in predialytic end-stage renal disease.Contr Nephrol 1984;41:299\u2013303.","journal-title":"Contr Nephrol"},{"key":"BF01857636_CR36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000184318","volume":"46","author":"G Lagrue","year":"1987","unstructured":"Lagrue G, Robeva R, Laurent J. Antiproteinuric effect of captopril in primary glomerular disease.Nephron 1987;46:99\u2013100.","journal-title":"Nephron"},{"key":"BF01857636_CR37","first-page":"719","volume":"17","author":"J-P Gassia","year":"1980","unstructured":"Gassia J-P, Durand D, Ton That H, et al. Long-term effect of captopril in hypertension with chronic renal failure.Proc Eur Dial Transpl Assoc 1980;17:719\u2013724.","journal-title":"Proc Eur Dial Transpl Assoc"},{"key":"BF01857636_CR38","first-page":"379","volume":"33","author":"G Maschio","year":"1988","unstructured":"Maschio G, Oldrizzi L, Rugiu C. Long-term clinical effects of enalapril (E) on progression of chronic renal failure (CRF).Kidney Int 1988;33:379.","journal-title":"Kidney Int"},{"key":"BF01857636_CR39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(87)93006-6","volume":"2","author":"J Mann","year":"1987","unstructured":"Mann J, Ritz E: Preservation of kidney function by use of converting enzyme inhibitors for control of hypertension.Lancet 1987;2:622.","journal-title":"Lancet"},{"key":"BF01857636_CR40","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/00005344-198507001-00019","volume":"7","author":"AC Jenkins","year":"1985","unstructured":"Jenkins AC, Dreslinski GR, Tadros SS, et al. Captopril in hypertension: Seven years later.J Cardiorase Pharmacol 1985;7:S96\u2013S101.","journal-title":"J Cardiorase Pharmacol"},{"key":"BF01857636_CR41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00007611-198504000-00001","volume":"78","author":"MS Laher","year":"1985","unstructured":"Laher MS, O'Donohoe JF, O'Regan P, et al. Captopril for refractory hypertension in patients with impaired renal function.J R Soc Med 1985;78:367\u2013372.","journal-title":"J R Soc Med"},{"key":"BF01857636_CR42","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/0002-9149(82)90362-9","volume":"49","author":"J Havelka","year":"1982","unstructured":"Havelka J, Vetter H, Studer A, et al. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.Am J Cardiol 1982;49:1467\u20131474.","journal-title":"Am J Cardiol"},{"key":"BF01857636_CR43","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF01725707","volume":"62","author":"W Vetter","year":"1984","unstructured":"Vetter W, Wehling M, Foerster E-Ch, et al. Long-term effect of captopril on kidney function in various forms of hypertension.Klin Wochenschr 1984;62:731\u2013737.","journal-title":"Klin Wochenschr"},{"key":"BF01857636_CR44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-111-6-503","volume":"111","author":"WF Keane","year":"1989","unstructured":"Keane WF, Anderson S, Aurell M. et al. angiotensin converting enzyme inhibitors and progressive renal insufficiency: Current experience and future directions.Ann Intern Med 1989;111:503\u2013516.","journal-title":"Ann Intern Med"},{"key":"BF01857636_CR45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.RES.36.2.286","volume":"36","author":"JM Kaufman","year":"1975","unstructured":"Kaufman JM, Siegel NJ, Hayslett JP. Functional and hemodynamic adaptation to progressive renal ablation.Circ Res 1975;36:286\u2013293.","journal-title":"Circ Res"},{"key":"BF01857636_CR46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1152\/ajplegacy.1974.227.3.556","volume":"227","author":"WM Deen","year":"1974","unstructured":"Deen WM, Maddox DA, Robertson CR, Brenner BM. Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass.Am J Physiol 1974;227:556\u2013562.","journal-title":"Am J Physiol"},{"key":"BF01857636_CR47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ki.1976.50","volume":"9","author":"ML Purkerson","year":"1976","unstructured":"Purkerson ML, Hoffsten PE, Klahr S. Pathogenesis of the glomerulopathy associated with renal infarction in rats.Kidney Int 1976;9:407\u2013417.","journal-title":"Kidney Int"},{"key":"BF01857636_CR48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ki.1973.57","volume":"3","author":"MEM Allison","year":"1973","unstructured":"Allison MEM, Lipham EM, Lassiter WE, et al. The acutely reduced kidney.Kidney Int 1973;3:354\u2013363.","journal-title":"Kidney Int"},{"key":"BF01857636_CR49","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1988.77","volume":"33","author":"Y Yoshida","year":"1988","unstructured":"Yoshida Y, Fogo A, Shiraga H, et al. Serial micropuncture analysis of single nephron function in subtotal renal ablation.Kidney Int 1988;33:855\u2013867.","journal-title":"Kidney Int"},{"key":"BF01857636_CR50","first-page":"375","volume":"109","author":"TH Hostetter","year":"1987","unstructured":"Hostetter TH. Progressive renal disease: Is the slippery slope species specific?J Lab Clin Med 1987;109:375\u2013377.","journal-title":"J Lab Clin Med"},{"key":"BF01857636_CR51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.RES.62.2.367","volume":"62","author":"BL Kasiske","year":"1988","unstructured":"Kasiske BL, O'Donnell MP, Garvis WJ, et al. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5\/6 nephrectomy model of chronic renal failure.Circ Res 1988;62:367\u2013374.","journal-title":"Circ Res"},{"key":"BF01857636_CR52","first-page":"598","volume":"106","author":"BL Kasiske","year":"1985","unstructured":"Kasiske BL, Cleary MP, O'Donnell MP, et al. Effects of genetic obesity on renal structure and function in the Zucker rat.J Lab Clin Med 1985;106:598\u2013604.","journal-title":"J Lab Clin Med"},{"key":"BF01857636_CR53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ki.1984.27","volume":"25","author":"JL Olson","year":"1984","unstructured":"Olson JL. Role of heparin as a protective agent following reduction of renal mass.Kidney Int 1984;25:376\u2013382.","journal-title":"Kidney Int"},{"key":"BF01857636_CR54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1172\/JCI113312","volume":"81","author":"ML Purkerson","year":"1988","unstructured":"Purkerson ML, Tollefsen DM, Klahr S. N-desulfated\/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.J Clin Invest 1988;81:69\u201374.","journal-title":"J Clin Invest"},{"key":"BF01857636_CR55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1988.228","volume":"34","author":"I Ichikawa","year":"1988","unstructured":"Ichikawa I, Yoshida Y, Fogo A, et al. Effect of heparin on the glomerular structure and function of remnant nephrons.Kidney Int 1988;34:638\u2013644.","journal-title":"Kidney Int"},{"key":"BF01857636_CR56","first-page":"605","volume":"106","author":"MP O'Donnell","year":"1985","unstructured":"O'Donnell MP, Kasiske BL, Cleary MP, et al. Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies.J Lab Clin Med 1985;106:605\u2013610.","journal-title":"J Lab Clin Med"},{"key":"BF01857636_CR57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.1975.96","volume":"8","author":"RC Pabico","year":"1975","unstructured":"Pabico RC, McKenna BA, Freeman RB: Renal function before and after unilateral nephrectomy in renal donors.Kidney Int 1975;8:166\u2013175.","journal-title":"Kidney Int"},{"key":"BF01857636_CR58","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/ki.1984.112","volume":"25","author":"RM Hakim","year":"1984","unstructured":"Hakim RM, Goldszer RC, Brenner BM. Hypertension and proteinuria: Long term sequelae of uninephrectomy in humans.Kidney Int 1984;25:930\u2013936.","journal-title":"Kidney Int"},{"key":"BF01857636_CR59","doi-asserted-by":"crossref","unstructured":"Mathillas O, Attman P-O, Aurell M, et al. Proteinuria and renal function in kidney transplant donors 10\u201318 years after donor uninephrectomy.Ups J Med Sci 985;90:37\u201342.","DOI":"10.3109\/03009738509178636"},{"key":"BF01857636_CR60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0002-9343(85)90010-5","volume":"79","author":"LJ Miller","year":"1985","unstructured":"Miller LJ, Suthanthiran M, Riggio RR, et al. Impact of renal donation.Am J Med 1985;79:201\u2013208.","journal-title":"Am J Med"},{"key":"BF01857636_CR61","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(85)92792-8","volume":"1","author":"P Robitaille","year":"1985","unstructured":"Robitaille P, Lortie L, Mongeau J, et al. Long-term follow-up of patients who underwent unilateral nephrectomy in childhood.Lancet 1985;1:1297\u20131299.","journal-title":"Lancet"},{"key":"BF01857636_CR62","first-page":"317","volume":"29","author":"C Deziel","year":"1986","unstructured":"Deziel C, Renda SA, Bichet D, et al. The evolution of chronic renal failure.Kidney Int 1986;29:317.","journal-title":"Kidney Int"},{"key":"BF01857636_CR63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI113302","volume":"81","author":"AYM Chan","year":"1988","unstructured":"Chan AYM, Cheng MLL, Keil LC, et al. Functional response of healthy and diseased glomeruli to a large, proteinrich meal.J Clin Invest 1988;81:245\u2013254.","journal-title":"J Clin Invest"},{"issue":"Suppl 20","key":"BF01857636_CR64","first-page":"229","volume":"31","author":"PK Carmines","year":"1987","unstructured":"Carmines PK, Perry MD, Hazelrig JB, et al. Effects of preglomerular and postglomerular vascular resistance alterations on filtration fraction.Kidney Int 1987;31 (Suppl 20):229\u2013232.","journal-title":"Kidney Int"},{"issue":"Suppl 17","key":"BF01857636_CR65","first-page":"S66","volume":"28","author":"C Giordano","year":"1985","unstructured":"Giordano C. Early dietary protein restriction protects the failing kidney.Kidney Int 1985;28 (Suppl 17):S66\u2013S70.","journal-title":"Kidney Int"},{"key":"BF01857636_CR66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ki.1982.184","volume":"22","author":"G Maschio","year":"1982","unstructured":"Maschio G, Oldrizzi L, Tessitore N, et al. Effects of dietary protein and phosphorus restriction on the progression of early renal failure.Kidney Int 1982;22:371\u2013376.","journal-title":"Kidney Int"},{"key":"BF01857636_CR67","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(84)90818-3","volume":"2","author":"JB Rosman","year":"1984","unstructured":"Rosman JB, Meijer S, Sluiter WJ, et al. Prospective randomised trial of early dietary protein restriction in chronic renal failure.Lancet 1984;2:1291\u20131295.","journal-title":"Lancet"},{"key":"BF01857636_CR68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJM198409063111002","volume":"311","author":"WE Mitch","year":"1984","unstructured":"Mitch WE, Walser M, Steinman TI, et al. The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure.N Engl J Med 1984; 311:623\u2013629.","journal-title":"N Engl J Med"},{"issue":"Suppl 16","key":"BF01857636_CR69","first-page":"S263","volume":"24","author":"N Gretz","year":"1983","unstructured":"Gretz N, Korb E, Strauch M. Low-protein diet supplemented by keto acids in chronic renal failure: A prospective controlled study.Kidney Int 1983;24 (Suppl 16):S263\u2013S267.","journal-title":"Kidney Int"},{"key":"BF01857636_CR70","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.1985.46","volume":"27","author":"L Oldrizzi","year":"1985","unstructured":"Oldrizzi L, Rugiu C, Valvo E, et al. Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet.Kidney Int 1985;27:553\u2013557.","journal-title":"Kidney Int"},{"key":"BF01857636_CR71","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198512263132601","volume":"313","author":"Y Taguma","year":"1985","unstructured":"Taguma Y, Kitamoto Y, Futaki G, et al. Effect of captopril on heavy proteinuria in azotemic diabetics.N Engl J Med 1985;313:1617\u20131620.","journal-title":"N Engl J Med"},{"key":"BF01857636_CR72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archinte.1986.00360160127017","volume":"146","author":"V Gutierrez-Millet","year":"1986","unstructured":"Gutierrez-Millet V, Neito J, Praga M, et al. Focal glomerulosclerosis and proteinuria in patients with solitary kidneys.Arch Intern Med 1986;146:705\u2013709.","journal-title":"Arch Intern Med"},{"key":"BF01857636_CR73","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/bmj.291.6509.1610","volume":"291","author":"LR Solomon","year":"1985","unstructured":"Solomon LR, Mallick NP, Lawler W. Progressive renal failure in a remnant kidney.Br Med J 1985;291:1610\u20131611.","journal-title":"Br Med J"},{"key":"BF01857636_CR74","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1542\/peds.73.6.806","volume":"73","author":"PS Thorner","year":"1984","unstructured":"Thorner PS, Arbus GS, Celermajer DS, Baumal R. Focal segmental glomerulosclerosis and progressive renal failure associated with a unilateral kidney.Pediatrics 1984;73:806\u2013810.","journal-title":"Pediatrics"},{"key":"BF01857636_CR75","first-page":"275","volume":"46","author":"DD Kiprov","year":"1982","unstructured":"Kiprov DD, Colvin RB, McCluskey RT. Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis.Lab Invest 1982;46:275\u2013281.","journal-title":"Lab Invest"},{"key":"BF01857636_CR76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000167579","volume":"8","author":"A Bohle","year":"1988","unstructured":"Bohle A, Biwer E, Christensen JA. Hyperfusion injury of the human kidney in different glomerular diseases.Am J Nephrol 1988;8:179\u2013186.","journal-title":"Am J Nephrol"},{"key":"BF01857636_CR77","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(83)92462-5","volume":"1","author":"H Parving","year":"1983","unstructured":"Parving H, Smidt UM, Andersen AR, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.Lancet 1983;1:1175\u20131179.","journal-title":"Lancet"},{"key":"BF01857636_CR78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.285.6343.685","volume":"285","author":"CE Mogensen","year":"1982","unstructured":"Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.Br Med J 1982;285:685\u2013688.","journal-title":"Br Med J"},{"key":"BF01857636_CR79","first-page":"81","volume-title":"The progressive Nature of Renal Disease: Contemporary Issues in Nephrology, Vol 14","author":"DS Baldwin","year":"1986","unstructured":"Baldwin DS, Neugarten J. Blood pressure control and progression of renal insufficiency. In: Brenner BM, Stein JH, eds.The progressive Nature of Renal Disease: Contemporary Issues in Nephrology, Vol 14. New York: Churchill Livingstone, 1986:81\u2013110."},{"key":"BF01857636_CR80","first-page":"1","volume":"25","author":"J Bergstrom","year":"1986","unstructured":"Bergstrom J, Alvestrand A, Bucht H, et al. Progression of chronic ranal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control.Cli Nephrol 1986;25:1\u20136.","journal-title":"Cli Nephrol"},{"issue":"Suppl 20","key":"BF01857636_CR81","first-page":"S132","volume":"31","author":"AJM Donker","year":"1986","unstructured":"Donker AJM. Nephrotoxicity of angiotensin converting enzyme inhibition.Kidney Int 1986;31 (Suppl 20):S132\u2013S137.","journal-title":"Kidney Int"},{"key":"BF01857636_CR82","first-page":"892","volume":"21","author":"G Boner","year":"1985","unstructured":"Boner G, Morduchowicz G, Rotenberg Z, et al. Deterioration in renal function in patients with chronic renal failure after treatment with captopril.Israel J Med Sci 1985;21:892\u2013894.","journal-title":"Israel J Med Sci"},{"key":"BF01857636_CR83","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.289.6436.20","volume":"289","author":"DL Verbeelen","year":"1984","unstructured":"Verbeelen DL, De Boel S. Reversible acute on chronic renal failure during captopril treatment.Br Med J 1984;289:20\u201321.","journal-title":"Br Med J"},{"key":"BF01857636_CR84","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0140-6736(85)92292-5","volume":"1","author":"F Brivet","year":"1985","unstructured":"Brivet F, Roulot D, Poitrine A, et al. Reversible acute renal failure during enalapril treatment in patient with chronic glomerulonephritis without renal artery stenosis.Lancet 1985;1:1512.","journal-title":"Lancet"},{"key":"BF01857636_CR85","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0002-9343(82)90415-6","volume":"73","author":"SC Textor","year":"1982","unstructured":"Textor SC, Bravo EL, Fouad FM, et al. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.Am J Med 1982;73:719\u2013725.","journal-title":"Am J Med"},{"key":"BF01857636_CR86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/clpt.1985.234","volume":"38","author":"MT Zenella","year":"1985","unstructured":"Zenella MT, Mattei E, Draibe SA, et al. Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure.Clin Pharmacol Ther 1985;38:613\u2013617.","journal-title":"Clin Pharmacol Ther"},{"key":"BF01857636_CR87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000167591","volume":"8","author":"T Sakemi","year":"1988","unstructured":"Sakemi T, Ohchi N, Sanai T, et al. Captopril-induced metabolic acidosis with hyperkalemia.Am J Nephrol 1988;8:245\u2013248.","journal-title":"Am J Nephrol"},{"key":"BF01857636_CR88","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.1984.00350190137023","volume":"144","author":"ED Frohlich","year":"1984","unstructured":"Frohlich ED, Cooper RA, Lewis EJ. Review of the overall experience of captopril in hypertension.Arch Intern Med 1984;144:1441\u20131444.","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"BF01857636_CR89","first-page":"30","volume":"10","author":"EJ Lewis","year":"1987","unstructured":"Lewis EJ. Angiotensin-converting enzyme inhibitors: Considerations regarding proteinuria.Am J Kidney Dis 1987;10 (suppl 1):30\u201338.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"BF01857636_CR90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9343(84)80055-8","volume":"77","author":"RO Davies","year":"1984","unstructured":"Davies RO, Irvin JD, Kramsch DK, et al. Enalapril worldwide experience.Am J Med 1984;77 (Suppl 2A):23\u201335.","journal-title":"Am J Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01857636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01857636\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01857636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T16:32:37Z","timestamp":1683131557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01857636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["BF01857636"],"URL":"https:\/\/doi.org\/10.1007\/bf01857636","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}